India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
Coronavirus chronicle
05 August, 2021, 10:05 pm
Last modified: 05 August, 2021, 10:08 pm
Panacea will then supply the doses to drugmaker Dr Reddy's Laboratories for distribution in India
Photo: Collected
India's Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V Covid-19 vaccine using the drug substance made by Russia's Generium.
Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories for distribution in India
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.